Summary: MAPS Founder and Executive Director Rick Doblin, Ph.D., joins the Lex Fridman Podcast to discuss the history of psychedelic substances in culture and research, the ways in which MAPS is working to shape the future of psychedelics, and much more.
“From the very beginning, MAPS was designed not for academic research into psychedelics, but drug development,” explains Doblin, “and that’s why I think we’re now years ahead of everybody else in terms of making a psychedelic-assisted therapy into a medicine.”